IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i2p701-d480817.html
   My bibliography  Save this article

Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study

Author

Listed:
  • Alicia Villavicencio

    (Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Carrer del Sol 15, 17004 Girona, Spain
    Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, C/Universitat de Girona 10, 17003 Girona, Spain
    Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), 17190 Girona, Spain)

  • Marta Solans

    (Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, C/Universitat de Girona 10, 17003 Girona, Spain
    Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), 17190 Girona, Spain
    Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Av. Monforte de Lemos 3-5, 28029 Madrid, Spain)

  • Lluís Zacarías-Pons

    (Research Group on Aging, Disability and Health, Girona Biomedical Research Institute (IDIBGI), 17190 Girona, Spain)

  • Anna Vidal

    (Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Carrer del Sol 15, 17004 Girona, Spain
    Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), 17190 Girona, Spain)

  • Montse Puigdemont

    (Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Carrer del Sol 15, 17004 Girona, Spain
    Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), 17190 Girona, Spain)

  • Josep Maria Roncero

    (Hematological Service, Josep Trueta University Hospital, Catalan Institute of Oncology, Avinguda de França, S/N, 17007 Girona, Spain)

  • Marc Saez

    (Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, C/Universitat de Girona 10, 17003 Girona, Spain
    Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Av. Monforte de Lemos 3-5, 28029 Madrid, Spain)

  • Rafael Marcos-Gragera

    (Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Carrer del Sol 15, 17004 Girona, Spain
    Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, C/Universitat de Girona 10, 17003 Girona, Spain
    Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), 17190 Girona, Spain
    Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Av. Monforte de Lemos 3-5, 28029 Madrid, Spain)

Abstract

This study aimed to examine the prevalence of comorbidities in patients diagnosed with chronic lymphocytic leukemia (CLL), and to assess its influence on survival and cause-specific mortality at a population-based level. Incident CLL cases diagnosed in the Girona province (Spain) during 2008–2016 were extracted from the Girona Cancer Registry. Rai stage and presence of comorbidities at diagnosis, further categorized using the Charlson comorbidity index (CCI), were obtained from clinical records. Observed (OS) and relative survival (RS) were estimated and Cox’s proportional hazard models were used to explore the impact of comorbidity on mortality. Among the 400 cases included in the study, 380 (99.5%) presented at least one comorbidity at CLL diagnosis, with diabetes without end organ damage (21%) being the most common disease. 5-year OS and RS were 68.8 (95% CI: 64.4–73.6) and 99.5 (95% CI 3.13–106.0), respectively, which decreased markedly with increasing CCI, particularly in patients with CCI ≥ 3. Multivariate analysis identified no statistically significant association between the CCI and overall CLL-related or CLL-unrelated mortality. In conclusion, a high CCI score negatively influenced the OS and RS of CLL patients, yet its effect on mortality was statistically non-significant when also considering age and the Rai stage.

Suggested Citation

  • Alicia Villavicencio & Marta Solans & Lluís Zacarías-Pons & Anna Vidal & Montse Puigdemont & Josep Maria Roncero & Marc Saez & Rafael Marcos-Gragera, 2021. "Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study," IJERPH, MDPI, vol. 18(2), pages 1-10, January.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:2:p:701-:d:480817
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/2/701/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/2/701/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Percy, C. & Stanek III, E. & Gloeckler, L., 1981. "Accuracy of cancer death certificates and its effect on cancer mortality statistics," American Journal of Public Health, American Public Health Association, vol. 71(3), pages 242-250.
    2. Maja Pohar Perme & Janez Stare & Jacques Estève, 2012. "On Estimation in Relative Survival," Biometrics, The International Biometric Society, vol. 68(1), pages 113-120, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Peter Sandiford & Dale Bramley, 2013. "Application of the modified PGW method for determining the smoking attributable fraction of deaths in New Zealand Maori, Pacific and non-Maori non-Pacific populations," Demographic Research, Max Planck Institute for Demographic Research, Rostock, Germany, vol. 28(7), pages 207-228.
    2. Jessica Ho & Irma Elo, 2013. "The Contribution of Smoking to Black-White Differences in U.S. Mortality," Demography, Springer;Population Association of America (PAA), vol. 50(2), pages 545-568, April.
    3. Angela B Mariotto & Zhaohui Zou & Christopher J Johnson & Steve Scoppa & Hannah K Weir & Bin Huang, 2018. "Geographical, racial and socio-economic variation in life expectancy in the US and their impact on cancer relative survival," PLOS ONE, Public Library of Science, vol. 13(7), pages 1-18, July.
    4. Peter Cnudde & Szilard Nemes & Maziar Mohaddes & John Timperley & Göran Garellick & Kristina Burström & Ola Rolfson, 2017. "Is Preoperative Patient-Reported Health Status Associated with Mortality after Total Hip Replacement?," IJERPH, MDPI, vol. 14(8), pages 1-13, August.
    5. Sho Komukai & Satoshi Hattori, 2017. "Doubly robust estimator for net survival rate in analyses of cancer registry data," Biometrics, The International Biometric Society, vol. 73(1), pages 124-133, March.
    6. Soetewey, Antoine & Legrand, Catherine & Denuit, Michel & Silversmit, Geert, 2023. "Health indices for disease incidence and duration in the Semi-Markov setting," LIDAM Discussion Papers ISBA 2023013, Université catholique de Louvain, Institute of Statistics, Biostatistics and Actuarial Sciences (ISBA).
    7. Nicolas Bovio & Michel Grzebyk & Patrick Arveux & Jean-Luc Bulliard & Arnaud Chiolero & Evelyne Fournier & Simon Germann & Isabelle Konzelmann & Manuela Maspoli & Elisabetta Rapiti & Irina Guseva Canu, 2022. "Work-Related Factors and Lung Cancer Survival: A Population-Based Study in Switzerland (1990–2014)," IJERPH, MDPI, vol. 19(21), pages 1-16, October.
    8. Adelaida García-Velasco & Lluís Zacarías-Pons & Helena Teixidor & Marc Valeros & Raquel Liñan & M. Carmen Carmona-Garcia & Montse Puigdemont & Walter Carbajal & Raquel Guardeño & Núria Malats & Eric D, 2020. "Incidence and Survival Trends of Pancreatic Cancer in Girona: Impact of the Change in Patient Care in the Last 25 Years," IJERPH, MDPI, vol. 17(24), pages 1-22, December.
    9. Olayidé Boussari & Laurent Bordes & Gaëlle Romain & Marc Colonna & Nadine Bossard & Laurent Remontet & Valérie Jooste, 2021. "Modeling excess hazard with time‐to‐cure as a parameter," Biometrics, The International Biometric Society, vol. 77(4), pages 1289-1302, December.
    10. Alessia Eletti & Giampiero Marra & Manuela Quaresma & Rosalba Radice & Francisco Javier Rubio, 2022. "A unifying framework for flexible excess hazard modelling with applications in cancer epidemiology," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 71(4), pages 1044-1062, August.
    11. Binbing Yu & Lan Huang & Ram C. Tiwari & Eric J. Feuer & Karen A. Johnson, 2009. "Modelling population‐based cancer survival trends by using join point models for grouped survival data," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 172(2), pages 405-425, April.
    12. Peter Sasieni & Adam R. Brentnall, 2017. "On standardized relative survival," Biometrics, The International Biometric Society, vol. 73(2), pages 473-482, June.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:2:p:701-:d:480817. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.